Mycobacterium tuberculosis drug resistance, Ghana - PubMed (original) (raw)

doi: 10.3201/eid1207.051028.

Ohene Adjei, Christian G Meyer, Rolf D Horstmann, Anthony Enimil, Thomas F Kruppa, Frank Bonsu, Edmund N L Browne, Margaret Amanua Chinbuah, Ivy Osei, John Gyapong, Christof Berberich, Tanja Kubica, Stefan Niemann, Sabine Ruesch-Gerdes

• PMID: 16848046
• PMCID: PMC3291045
• DOI: 10.3201/eid1207.051028

Mycobacterium tuberculosis drug resistance, Ghana

Ellis Owusu-Dabo et al. Emerg Infect Dis. 2006 Jul.

No abstract available

PubMed Disclaimer

Similar articles

• Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
  Sangaré L, Diandé S, Badoum G, Dingtoumda B, Traoré AS. Sangaré L, et al. Int J Tuberc Lung Dis. 2010 Nov;14(11):1424-9. Int J Tuberc Lung Dis. 2010. PMID: 20937182
• Drug resistant Mycobacterium tuberculosis.
  Lim VK. Lim VK. Med J Malaysia. 1993 Jun;48(2):97-8. Med J Malaysia. 1993. PMID: 8350810 No abstract available.
• Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005.
  Zazueta-Beltran J, León-Sicairos N, Muro-Amador S, Flores-Gaxiola A, Velazquez-Roman J, Flores-Villaseñor H, Canizalez-Roman A. Zazueta-Beltran J, et al. Int J Infect Dis. 2011 Apr;15(4):e272-6. doi: 10.1016/j.ijid.2011.01.001. Epub 2011 Feb 12. Int J Infect Dis. 2011. PMID: 21317004
• Extensively drug-resistant tuberculosis: new strains, new challenges.
  Banerjee R, Schecter GF, Flood J, Porco TC. Banerjee R, et al. Expert Rev Anti Infect Ther. 2008 Oct;6(5):713-24. doi: 10.1586/14787210.6.5.713. Expert Rev Anti Infect Ther. 2008. PMID: 18847407 Review.
• [Appearance varied, complex diagnostics. Clinical aspects of tuberculosis].
  Müller A. Müller A. Pharm Unserer Zeit. 2012 Jan;41(1):27-34. doi: 10.1002/pauz.201100450. Pharm Unserer Zeit. 2012. PMID: 22470916 Review. German. No abstract available.

Cited by

• Second-line anti-tuberculosis drug resistance testing in Ghana identifies the first extensively drug-resistant tuberculosis case.
  Osei-Wusu S, Amo Omari M, Asante-Poku A, Darko Otchere I, Asare P, Forson A, Otu J, Antonio M, Yeboah-Manu D. Osei-Wusu S, et al. Infect Drug Resist. 2018 Feb 22;11:239-246. doi: 10.2147/IDR.S152720. eCollection 2018. Infect Drug Resist. 2018. PMID: 29503573 Free PMC article.
• MCP-1 promoter variant -362C associated with protection from pulmonary tuberculosis in Ghana, West Africa.
  Thye T, Nejentsev S, Intemann CD, Browne EN, Chinbuah MA, Gyapong J, Osei I, Owusu-Dabo E, Zeitels LR, Herb F, Horstmann RD, Meyer CG. Thye T, et al. Hum Mol Genet. 2009 Jan 15;18(2):381-8. doi: 10.1093/hmg/ddn352. Epub 2008 Oct 20. Hum Mol Genet. 2009. PMID: 18940815 Free PMC article.
• Trends of Mycobacterium tuberculosis and rifampicin resistance at the Ho Teaching Hospital in Ghana.
  Deku JG, Aninagyei E, Bedzina I, Nudo G, Ativi E, Mensah P, Wireko S, Osei-Tutu A, Duker E, Afeke I. Deku JG, et al. PLoS One. 2024 Jun 10;19(6):e0305161. doi: 10.1371/journal.pone.0305161. eCollection 2024. PLoS One. 2024. PMID: 38857257 Free PMC article.
• Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis.
  Thye T, Niemann S, Walter K, Homolka S, Intemann CD, Chinbuah MA, Enimil A, Gyapong J, Osei I, Owusu-Dabo E, Rüsch-Gerdes S, Horstmann RD, Ehlers S, Meyer CG. Thye T, et al. PLoS One. 2011;6(6):e20908. doi: 10.1371/journal.pone.0020908. Epub 2011 Jun 10. PLoS One. 2011. PMID: 21695215 Free PMC article.
• High Frequency of First-Line Anti-Tuberculosis Drug Resistance among Persons with Chronic Pulmonary Tuberculosis at a Teaching Hospital Chest Clinic.
  Forson A, Kudzawu S, Kwara A, Flanigan T. Forson A, et al. Ghana Med J. 2010 Jun;44(2):42-6. doi: 10.4314/gmj.v44i2.68858. Ghana Med J. 2010. PMID: 21327002 Free PMC article.

References

1. 1. National Tuberculosis Control Programme. Annual report 2003. Accra (Ghana): The Programme; 2003.
2. 1. van der Werf TS, Groothuis DG, van Klingeren B. High initial drug resistance in pulmonary tuberculosis in Ghana. Tubercle. 1989;70:249–55. 10.1016/0041-3879(89)90019-6 - DOI - PubMed
3. 1. Lawn SD, Frimpong EH, Al-Ghusein H, Acheampong JW, Uttley AH, Butcher PD, et al. Pulmonary tuberculosis in Kumasi, Ghana: presentation, drug resistance, molecular epidemiology and outcome of treatment. West Afr J Med. 2001;20:92–7. - PubMed
4. 1. Farmer P, Bayona J, Becerra M, Furin J, Henry C, Hiatt H, et al. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis. 1998;2:869–76. - PubMed
5. 1. World Health Organization. Anti-tuberculosis drug resistance in the world. Third global report. WHO/HTM/TB/2004.323. Geneva: The Organization; 2004

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central